Oruka Therapeutics

Principal Scientist – Analytical Development, Tech Ops, Biologics

Oruka Therapeutics

full-time

Posted on:

Location Type: Hybrid

Location: Waltham • Massachusetts • 🇺🇸 United States

Visit company website
AI Apply
Apply

Salary

💰 $175,000 - $230,000 per year

Job Level

Senior

About the role

  • Lead external method development, optimization and qualification/validation efforts across liquid chromatography, capillary electrophoresis, spectrophotometric and bioassay (among others) for release and stability testing of clinical trial materials.
  • Manage multiple non-GMP and GMP stability studies for drug substance (DS) and drug product (DP) batches for multiple programs.
  • Leverage stability data to project shelf-life of both DS and DP supply through trending analysis.
  • Develop strategies to establish characterization and comparability packages across various DS/DP lots.
  • Support process and manufacturing teams towards implementation of relevant analytical methods.
  • Work closely with cross-functional stakeholders (QA, Regulatory, Clinical Supply Chain) for shelf-life extension of clinical material to support ongoing clinical trials.
  • Partner with internal and external stakeholders to justify and establish DS/DP protocols and specifications.
  • Work with CDMO partners to perform root cause analysis and investigations to support OOS/OOT results that may arise during stability studies.
  • Contribute to IND/BLA sections pertaining to analytical methods, stability studies, characterization and analytical comparability.
  • Lead the diligence process to select clinical and commercial CDMO vendors.
  • Partner with operations, legal, and finance groups to finalize confidentiality, master service and contractual agreements.
  • 20-25% travel in support of diligence and campaign execution at the CDMOs.

Requirements

  • Associate Director: Master’s (10+ years) or a PhD (6+ years) or Principal Scientist: Master’s (6+ years) or PhD (4+ years) with experience in a scientific discipline with relevant experience in analytical development and/or QC. Experience with monoclonal antibodies is a requirement.
  • Relevant industry experience in method development, qualification, validation and method transfer in support of ongoing development and/or commercialization of biologics.
  • Experience with methods including but not limited to U/HPLC, Capillary Electrophoresis, Spectrophotometer, Bioassay (ELISA and Cell-Based)
  • Deep understanding of ICH guidelines for method development/qualification and validation as well as regulatory expectations in US, Canada, EU, etc.
  • Experience managing multiple stability studies, protocol development and performing trending analysis, OOS/OOT investigations, root cause analysis, etc.
  • Experience in authoring/contributing to regulatory filings, specifically Module 3 for analytical methods and stability studies.
  • Demonstrated track record of successful tech transfers between CDMOs with an eye towards late-stage development and commercial launch.
  • Excellent writing, organization, communication and people management skills with the ability to work effectively with a diverse group of internal and external stakeholders.
  • Must have a creative and strategic attitude with the ability to work in a fast-paced environment.
Benefits
  • Competitive salary and benefits package.
  • Opportunities for professional growth and development.
  • A supportive and inclusive team environment where everyone is encouraged to bring their authentic selves to work.
  • A chance to be part of a vibrant startup culture where your work can directly impact bringing new medicines to patients.

Applicant Tracking System Keywords

Tip: use these terms in your resume and cover letter to boost ATS matches.

Hard skills
liquid chromatographycapillary electrophoresisspectrophotometrybioassayU/HPLCELISAcell-based assaysmethod developmentqualificationvalidation
Soft skills
writingorganizationcommunicationpeople managementstrategic thinkingcreativitycollaborationproblem-solvingadaptabilitystakeholder engagement